HOME >> BIOLOGY >> NEWS
UNC Researchers Reduce Arthritis Severity By Turning Off Molecular Switch

CHAPEL HILL, N.C. --In a scientific first, researchers at the University of North Carolina at Chapel Hill have reduced the severity of arthritis by turning off a molecular switch, a gene called NF-kappa B.

A report published Nov. 10 in the Proceedings of the National Academy of Sciences says the findings, based on experiments in laboratory rats, establish an important molecular mechanism in human rheumatoid arthritis. The findings demonstrate the feasibility of new ways to treat the disease, including gene therapy.

"These findings underscore NF-kappa B as a very attractive target for arthritis treatments, including a new generation of drugs targeted specifically to the molecule," says the team's leader, Dr. Sergei S. Makarov, research assistant professor of medicine at the UNC-CH School of Medicine and the Thurston Arthritis Research Center.

"In rheumatoid arthritis, the delicate synovial joint lining dramatically expands and transforms into an aggressive, tumor-like structure that invades and erodes the joint," Makarov says. "We started studying the role for NF-kappa B in arthritis because it controls the expression of numerous inflammatory genes, and we knew that it's activated within the arthritic synovium. Around that time, our collaborator, Dr. Al Baldwin, published his pioneer study demonstrating that activated NF-kappa B is needed to protect cancer cells in vitro from apoptosis, or programmed cell death."

From their subsequent in vitro studies, Makarov and his colleagues learned that similar mechanisms might operate in rheumatoid arthritis. "We found that inflammatory stimuli caused activation of NF-kappa B inside the cells from arthritic joints, rendering them resistant to apoptosis. It seemed that the more inflammation you had, the more protected those cells were against apoptosis," he says.

"We then predicted that if you block NF-kappa B in the arthritic joint, inflammation would go down, the cells would no longer be protected ag
'"/>

Contact: Lynn Wooten
lwooten.est1@mail.unch.unc.edu
919-966-6046
University of North Carolina School of Medicine
2-Nov-1998


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the ... share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content ... will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... B.V. (MBS) has announced a publication detailing the use of its revolutionary ... polymerase chain reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
(Date:7/1/2020)... N.C. (PRWEB) , ... June 29, 2020 , ... ... reported year to date growth of 40% in 2020, despite many obstacles created ... technology, MedShift aims to increase revenue for its partnered medical practices and medical ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... today announced the company has entered a license agreement with Roswell Park Comprehensive ... globally exclusive rights to Roswell Park intellectual property surrounding a novel medical device ...
(Date:6/23/2020)... ... June 22, 2020 , ... Dracen Pharmaceuticals Inc., ... presented June 22-24 during the American Association for Cancer Research Virtual meeting. One ... the potent, consistent single agent activity in KEAP1 mutant tumor models of NSCLC. ...
Breaking Biology Technology:
Cached News: